Earnings season is starting to wind down but we still have some big names due to report Q3 numbers. This week, we have Costco (COST), Broadcom (AVGO), Adobe Systems (ADBE) and Oracle (ORCL) all set to report. More News from Barchart Before a company reports earnings, implied volatility is usually high because the market is unsure about the outcome of the report. Speculators and hedgers create huge demand for the company’s options which increases the implied volatility, and therefore, the price of option ...

Core Viewpoint - Compass Minerals International, Inc. is expected to report a quarterly loss of 23 cents per share for Q4, an improvement from a loss of 77 cents per share a year ago, with projected revenue of $223.72 million, up from $208.8 million year-over-year [1] Group 1: Earnings and Revenue Expectations - The company will release its Q4 earnings results on December 8 [1] - Analysts predict a quarterly loss of 23 cents per share, compared to a loss of 77 cents per share in the same quarter last year [1] - The consensus estimate for quarterly revenue is $223.72 million, an increase from $208.8 million a year earlier [1] Group 2: Recent Performance and Analyst Ratings - On August 11, the company reported worse-than-expected Q3 earnings and narrowed its FY25 sales guidance [2] - Following the earnings report, Compass Minerals shares rose by 1.7% to close at $20.12 [2] - JP Morgan analyst downgraded the stock from Overweight to Underweight, raising the price target from $15 to $18 [4] - Deutsche Bank maintained a Buy rating and increased the price target from $14 to $22 [4] - BMO Capital maintained a Market Perform rating and raised the price target from $15 to $20 [4]

It has been about a month since the last earnings report for DoorDash, Inc. (DASH) . Shares have added about 12.6% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is DoorDash due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.DASH Q3 Earnin ...

Core Viewpoint - Joby Aviation, Inc. has experienced a 10.1% increase in share price over the past month, outperforming the S&P 500, but concerns remain about the sustainability of this trend leading up to the next earnings report [1][2]. Financial Performance - Joby reported a third-quarter 2025 loss of 26 cents per share, which was wider than the Zacks Consensus Estimate of 19 cents and the previous year's loss of 21 cents [3]. - Quarterly revenues reached $22.6 million, significantly exceeding the Zacks Consensus Estimate by 140.2%, compared to only $0.03 million in the same quarter last year [3]. - Total operating expenses increased by 30.3% year over year, driven by a rise in research and development costs (up 18.2%) and selling, general, and administrative costs (up 47%) [4]. - Adjusted EBITDA for the third quarter was a loss of $132.8 million, which included costs related to employee expenses for aircraft development and the Blade acquisition [4]. - At the end of the third quarter, Joby had cash and cash equivalents of $208.4 million, up from $199.6 million at the end of 2024, with expectations to generate cash and short-term investments in the range of $500-$540 million for 2025 [5]. Estimate Revisions - There has been a downward trend in estimates, with the consensus estimate shifting down by 8.33% over the past month [6]. - Joby Aviation currently holds a Zacks Rank 3 (Hold), indicating an expectation of an in-line return in the coming months [8]. VGM Scores - Joby Aviation has a poor Growth Score of F, a Momentum Score of F, and a Value Score of F, placing it in the fifth quintile for investment strategy [7]. Industry Comparison - Joby Aviation is part of the Zacks Aerospace - Defense industry, where General Dynamics has seen a slight gain of 0.4% over the past month, reporting revenues of $12.91 billion for the quarter ended September 2025, reflecting a year-over-year increase of 10.6% [9].

Core Viewpoint - Revolution Medicines, Inc. has experienced a 27.9% increase in share price over the past month, outperforming the S&P 500, but faces challenges ahead of its next earnings release [1] Financial Performance - For Q3 2025, Revolution Medicines reported a loss of $1.61 per share, which was wider than the expected loss of $1.39, compared to a loss of $0.94 in the same quarter last year [2] - The company has not generated any revenue as it currently lacks approved products in its portfolio [2] Expense Analysis - Research and development expenses reached approximately $263 million, reflecting a 73% year-over-year increase, driven by higher clinical study costs and employee-related expenses [3] - General and administrative expenses were nearly $53 million, up 120% year-over-year, primarily due to increased employee-related costs [3] Guidance - The company maintained its full-year operating expenses guidance, expecting a range between $1.03 billion and $1.09 billion, which includes non-cash stock-based compensation expenses of $115-$130 million [4] Estimate Trends - There has been a downward trend in consensus estimates, with a shift of -5.4% over the past month [5] VGM Scores - Revolution Medicines holds a poor Growth Score of F, a Momentum Score of F, and a Value Score of F, placing it in the bottom 20% quintile for investment strategies [6] Outlook - The overall trend for estimates has been downward, with a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [7] Industry Comparison - Revolution Medicines is part of the Zacks Medical - Biomedical and Genetics industry, where Biogen Inc. has seen a 16.1% gain over the past month [8] - Biogen reported revenues of $2.53 billion for the last quarter, a year-over-year increase of 2.8%, with an EPS of $4.81 compared to $4.08 a year ago [9]

Core Insights - Steven Madden's Q3 2025 earnings report showed a decline in earnings and a mixed performance in revenues, with total revenues increasing but earnings per share (EPS) falling significantly [3][4]. Financial Performance - Adjusted quarterly earnings were reported at 43 cents per share, missing the Zacks Consensus Estimate of 44 cents, and down 52.7% from 91 cents in the prior-year period [4]. - Total revenues rose 6.9% year over year to $667.9 million, but this figure missed the consensus estimate of $699 million [4]. - Adjusted gross profit increased by 11.6% year over year to $289.7 million, surpassing the estimate of $278.5 million, with an adjusted gross margin expanding 180 basis points to 43.4% [5]. - Adjusted operating income fell to $46.3 million, down 45.8% from the prior-year quarter, with an adjusted operating margin decreasing 680 basis points to 6.9% [6]. Segment Performance - Wholesale revenues totaled $442.7 million, a decline of 10.7% year over year, with a 19% decrease when excluding the recently acquired Kurt Geiger business [7]. - Direct-to-consumer revenues increased significantly by 76.6% year over year to $221.5 million, although this growth was only 1.5% when excluding Kurt Geiger [9]. Financial Health - As of the end of the quarter, the company had cash and cash equivalents of $108.7 million and stockholders' equity of $886.1 million [10]. - A cash dividend of 21 cents per share was announced, payable on December 26, 2025 [11]. Future Outlook - For Q4 2025, the company expects revenues to rise by 27% to 30% year over year, with EPS forecasted between 30 cents and 35 cents [13]. - The contribution from Kurt Geiger is anticipated to range between $182 million and $187 million in revenues for Q4, with a significant portion coming from direct-to-consumer operations [14]. Market Sentiment - Since the earnings release, there has been an upward trend in estimates, with the consensus estimate shifting by 66.67% [15]. - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations for above-average returns in the coming months [17].

Core Viewpoint - Devon Energy has shown a positive performance with a 16.3% increase in shares since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Financial Performance - Devon Energy reported Q3 2025 earnings per share (EPS) of $1.04, exceeding the Zacks Consensus Estimate of 93 cents by 11.8%, although this represents a 5.5% decline year over year [2] - Total revenues for the quarter reached $4.33 billion, surpassing the Zacks Consensus Estimate of $4.11 billion by 5.17% [4] - GAAP EPS for the quarter was $1.09, down from $1.41 in the same quarter last year, with differences attributed to asset disposition gains and changes in tax laws [3] Production Metrics - Net production in Q3 totaled 853,000 barrels of oil equivalent per day (Boe/d), a 17.2% increase year over year, exceeding the guidance range of 829,000-847,000 Boe/d [5] - Natural gas liquids production rose by 17.5% year over year to 228,000 barrels per day (Bbl/d), while oil production increased by 16.4% to 390,000 Bbl/d, driven by strong contributions from the Rockies region [6] Price Realization - Realized oil prices for the quarter were $63.99 per barrel, down 13.8% from $74.26 a year ago, while realized prices for natural gas liquids were $17.18 per barrel, down 11.3% [7] - Total oil equivalent realized prices, including cash settlements, were $36.46 per Boe, reflecting a nearly 10.4% year-over-year decline [7][9] Cost and Expenses - Total production expenses in Q3 amounted to $895 million, a 17.3% increase year over year, with production costs averaging $11.41 per Boe, down 3% sequentially [8] - The company repurchased shares worth $250 million and paid dividends of $151 million during the quarter [8] Financial Position - As of September 30, 2025, Devon had cash and cash equivalents of $1.28 billion, up from $0.85 billion at the end of 2024, while long-term debt decreased to $7.39 billion from $8.88 billion [10] - Net cash from operating activities was $1.69 billion in Q3 2025, slightly up from $1.66 billion in Q3 2024, with capital expenditures totaling $0.87 billion [11] Future Guidance - For Q4, production is expected to be in the range of 828,000-844,000 Boe/d, with capital spending estimated between $0.89 billion and $0.95 billion [12] - In 2026, the company aims to maintain production at approximately 835,000-855,000 Boe/d, with capital expenditures projected between $3.5 billion and $3.7 billion [13] Market Sentiment - There has been a downward trend in estimates, with the consensus estimate shifting down by 5.79% over the past month [14] - Devon Energy currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [16]

Core Insights - Hovnanian Enterprises, Inc. reported an EPS of -$0.51, missing the expected $0.63, but achieved revenue of $818 million, surpassing estimates of $814.5 million, indicating strong sales performance despite challenges in the housing market [2][5] - The company experienced a net loss of $667,000, influenced by hesitant homebuyers and increased incentives to maintain sales, which negatively impacted profitability [3] - The gross margin percentage declined to 10.7% from 18% the previous year, attributed to higher costs and tighter margins, affecting overall financial performance [4][5] Financial Metrics - Hovnanian's price-to-sales ratio is approximately 0.91, suggesting the stock is trading at a modest level relative to its revenue [4] - The enterprise value to sales ratio stands at around 1.15, reflecting the company's total valuation in relation to its sales [4] - The current ratio is about 3.84, indicating strong liquidity and the ability to cover short-term liabilities effectively [4]

Core Insights - Ulta Beauty, Inc. reported Q3 earnings of $5.14 per share, surpassing analyst expectations of $4.54 by 13.27% [1] - Quarterly revenue reached $2.858 billion, exceeding the Street estimate of $2.72 billion and up from $2.53 billion in the same period last year [2] Financial Performance - Net sales increased by 12.9% to $2.9 billion compared to $2.5 billion in the prior year quarter [5] - Comparable sales rose by 6.3% [5] - Gross profit increased by 14.9% to $1.2 billion from $1 billion [5] Strategic Outlook - The company raised its fiscal 2025 GAAP EPS guidance to between $25.20 and $25.50, compared to the previous analyst estimate of $24.40 [4] - Fiscal year revenue guidance was increased to approximately $12.3 billion, exceeding the prior estimate of $12.13 billion [4] Operational Highlights - During Q3, Ulta opened 28 new stores, remodeled 15 stores, and closed one store [5] - CEO Kecia Steelman noted that the results reflect the progress of the Ulta Beauty Unleashed Strategy, highlighting strong sales results and market share gains across all categories and channels, particularly in ecommerce [3][4]

Key Takeaways Brown-Forman posted lower EPS and sales, with revenues beating estimates year over year.BF.B saw mixed market performance, with U.S. and Developed International declines.Brown-Forman raised its dividend and reaffirmed guidance amid a tough backdrop.Brown-Forman Corporation (BF.B) has reported mixed second-quarter fiscal 2026 results, wherein the top line beat the Zacks Consensus Estimate, while the bottom line missed the same. Both sales and earnings declined year over year. The fiscal second- ...